205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
18.18%
Net income growth similar to MRVL's 17.65%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
0.26%
Less D&A growth vs. MRVL's 3.03%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-1028.57%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-58.21%
Negative yoy working capital usage while MRVL is 43.26%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
104.24%
Inventory growth well above MRVL's 103.12%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-317.65%
Both reduce yoy usage, with MRVL at -223.14%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
440.00%
Growth of 440.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
34.92%
Operating cash flow growth below 50% of MRVL's 474.06%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-43.83%
Both yoy lines negative, with MRVL at -13.08%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-11.34%
Negative yoy purchasing while MRVL stands at 69.19%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.22%
We have some liquidation growth while MRVL is negative at -23.95%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
-76.52%
We reduce yoy invests while MRVL stands at 88.80%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-63.83%
Both yoy lines negative, with MRVL at -86.93%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
1.64%
Buyback growth of 1.64% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.